HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Xiangxiang Xu Selected Research
Xiangxiang Xu Research Topics
Disease
4
Neoplasms (Cancer)
07/2023 - 01/2020
2
Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2018
2
Adenocarcinoma
01/2020 - 01/2020
2
Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 11/2011
2
Hypoxia (Hypoxemia)
01/2016 - 11/2011
1
Colonic Neoplasms (Colon Cancer)
07/2023
1
Lung Neoplasms (Lung Cancer)
07/2022
1
Fibrosis (Cirrhosis)
12/2021
1
Chronic Pancreatitis
01/2020
1
Inflammation (Inflammations)
01/2019
1
Pancreatitis
01/2019
1
Carcinogenesis
01/2018
1
Hyperglycemia
01/2018
1
Diabetes Mellitus
01/2018
Drug/Important Bio-Agent (IBA)
2
Competitive Endogenous RNA
IBA
01/2020 - 01/2020
2
Chorionic Gonadotropin (Human Chorionic Gonadotropin)
FDA Link
Generic
01/2016 - 11/2011
1
Nanovaccines
IBA
07/2023
1
Hydrazones
IBA
07/2022
1
Copper
IBA
07/2022
1
Vitamin B 6
IBA
07/2022
1
Platinum
IBA
07/2022
1
Proteins (Proteins, Gene)
FDA Link
12/2021
1
dibutyldichlorotin
IBA
01/2020
1
RNA (Ribonucleic Acid)
IBA
01/2020
1
Small Nucleolar RNA (snoRNA)
IBA
01/2020
1
Small Nucleolar Ribonucleoproteins
IBA
01/2020
1
di-n-butyltin (dibutyltin)
IBA
01/2020
1
Dipeptidyl-Peptidase IV Inhibitors
IBA
01/2019
1
Glucose (Dextrose)
FDA Link
Generic
01/2018
1
pyrazolanthrone
IBA
01/2018
1
Factor VIII (Coagulation Factor VIII)
IBA
01/2016
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016
1
Small Interfering RNA (siRNA)
IBA
01/2016
Therapy/Procedure
1
Immunotherapy
07/2023